Aucta Drug Patent Portfolio
Aucta owns 1 orange book drug protected by 3 US patents Given below is the list of Aucta's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11337943 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
| US11883374 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
| US12042474 | Lacosamide pharmaceutical composition and dosage form thereof | 05 Jun, 2040 | Active |
Latest Legal Activities on Aucta's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Aucta.
| Activity | Date | Patent Number |
|---|---|---|
| ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 10 Jun, 2025 | US11337943 |
| Patent Issue Date Used in PTA Calculation | 23 Jul, 2024 | US12042474 |
| Patent eGrant Notification | 23 Jul, 2024 | US12042474 |
| Email Notification | 23 Jul, 2024 | US12042474 |
| Mail Patent eGrant Notification | 23 Jul, 2024 | US12042474 |
| Recordation of Patent Grant Mailed | 23 Jul, 2024 | US12042474 |
| Recordation of Patent eGrant | 23 Jul, 2024 | US12042474 |
| Email Notification | 04 Jul, 2024 | US12042474 |
| Issue Notification Mailed | 03 Jul, 2024 | US12042474 |
| Application Is Considered Ready for Issue | 20 Jun, 2024 | US12042474 |
| Dispatch to FDC | 20 Jun, 2024 | US12042474 |
| Issue Fee Payment Received | 11 Jun, 2024 | US12042474 |
| Issue Fee Payment Verified | 11 Jun, 2024 | US12042474 |
| Electronic Review | 27 Mar, 2024 | US12042474 |
| Mail Notice of Allowance | 27 Mar, 2024 | US12042474 |
Aucta's Family Patents
Aucta Drug List
Given below is the complete list of Aucta's drugs and the patents protecting them.
1. Motpoly Xr
Motpoly Xr is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11337943 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(14 years from now)
| Active |
| US11883374 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(14 years from now)
| Active |
| US12042474 | Lacosamide pharmaceutical composition and dosage form thereof |
05 Jun, 2040
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Motpoly Xr's drug page